Myeloid dendritic cells are potential players in human neurodegenerative diseases
Alzheimer’s (AD) and Parkinson’s (PD) diseases are devastating neurodegenerative disturbances wherein neuroinflammation is a chronic pathogenic process with high therapeutic potential. Major mediators of AD/PD neuroimmune processes are resident immune cells, but immune cells derived from periphery...
Main Authors: | Paola eBossù, Gianfranco eSpalletta, Carlo eCaltagirone, Antonio eCiaramella |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00632/full |
Similar Items
-
Paradigm shift in dendritic cell-based immunotherapy: from in vitro generated monocyte-derived DCs to naturally circulating DC subsets
by: Florian eWimmers, et al.
Published: (2014-04-01) -
THE EMERGING ROLE OF MONOCYTE-DERIVED CELLS IN THE CENTRAL NERVOUS SYSTEM
by: Eva eRajnavolgyi
Published: (2016-06-01) -
Redefining myeloid cell subsets in murine spleen
by: Ying eHey, et al.
Published: (2016-01-01) -
Dendritic cells during Epstein Barr virus infection
by: Christian eMunz
Published: (2014-06-01) -
Human Dendritic Cells: Ontogeny and Their Subsets in Health and Disease
by: Sandra Georgina Solano-Gálvez, et al.
Published: (2018-10-01)